Karoline Droebner

588 total citations
18 papers, 467 citations indexed

About

Karoline Droebner is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Karoline Droebner has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Karoline Droebner's work include Influenza Virus Research Studies (8 papers), interferon and immune responses (7 papers) and Immune Response and Inflammation (7 papers). Karoline Droebner is often cited by papers focused on Influenza Virus Research Studies (8 papers), interferon and immune responses (7 papers) and Immune Response and Inflammation (7 papers). Karoline Droebner collaborates with scholars based in Germany, Croatia and Greece. Karoline Droebner's co-authors include Oliver Planz, Stephan Ludwig, Stephan Pleschka, Emanuel Haasbach, Sarah J. Reiling, Peter Sandner, Peter Kolkhof, Mira Pavkovic, Frank Eitner and Elke Hartmann and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Journal of the American Society of Nephrology.

In The Last Decade

Karoline Droebner

18 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karoline Droebner Germany 10 192 181 134 129 68 18 467
Liyan Wu China 12 241 1.3× 59 0.3× 144 1.1× 53 0.4× 23 0.3× 29 503
I. Haviv Australia 9 205 1.1× 60 0.3× 310 2.3× 64 0.5× 27 0.4× 13 581
D Pfeil Germany 7 116 0.6× 325 1.8× 181 1.4× 22 0.2× 37 0.5× 14 575
Shyamala Thirunavukkarasu United States 13 137 0.7× 93 0.5× 84 0.6× 36 0.3× 25 0.4× 26 348
Vera Nief Switzerland 6 52 0.3× 57 0.3× 177 1.3× 77 0.6× 86 1.3× 7 434
Qingming Dong China 14 226 1.2× 134 0.7× 228 1.7× 67 0.5× 10 0.1× 35 764
Weiwen Liang China 13 90 0.5× 87 0.5× 144 1.1× 36 0.3× 21 0.3× 23 413
Xiaomei Li China 12 209 1.1× 39 0.2× 136 1.0× 44 0.3× 14 0.2× 22 428
Amina Negash United States 8 344 1.8× 307 1.7× 364 2.7× 19 0.1× 80 1.2× 10 930
Xuelin He China 6 37 0.2× 140 0.8× 127 0.9× 78 0.6× 29 0.4× 14 438

Countries citing papers authored by Karoline Droebner

Since Specialization
Citations

This map shows the geographic impact of Karoline Droebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karoline Droebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karoline Droebner more than expected).

Fields of papers citing papers by Karoline Droebner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karoline Droebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karoline Droebner. The network helps show where Karoline Droebner may publish in the future.

Co-authorship network of co-authors of Karoline Droebner

This figure shows the co-authorship network connecting the top 25 collaborators of Karoline Droebner. A scholar is included among the top collaborators of Karoline Droebner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karoline Droebner. Karoline Droebner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Droebner, Karoline, Mira Pavkovic, Manuel Grundmann, et al.. (2021). Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis. American Journal of Nephrology. 52(7). 588–601. 46 indexed citations
2.
Kolkhof, Peter, Elke Hartmann, Alexius Freyberger, et al.. (2021). Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage. American Journal of Nephrology. 52(8). 642–652. 100 indexed citations
3.
Droebner, Karoline, Mira Pavkovic, Manuel Grundmann, et al.. (2020). The Novel Nonsteroidal and Selective Mineralocorticoid Receptor Antagonist Finerenone Differentiates from SGLT2 Inhibitor Empagliflozin by Anti-Fibrotic Effects in a Progressive Mouse Kidney Fibrosis Model. Journal of the American Society of Nephrology. 31(10S). 244–244. 1 indexed citations
4.
Droebner, Karoline, Emanuel Haasbach, Sabine Eva Dudek, et al.. (2017). Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug. Frontiers in Microbiology. 8. 2130–2130. 19 indexed citations
5.
Droebner, Karoline & Peter Sandner. (2013). Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test. Journal of Cystic Fibrosis. 12(6). 630–637. 13 indexed citations
6.
Haasbach, Emanuel, Sarah J. Reiling, Christina Ehrhardt, et al.. (2013). The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. Antiviral Research. 99(3). 336–344. 37 indexed citations
7.
Droebner, Karoline, Qinan Mao, & Peter Sandner. (2013). 50 Modification of the salivary secretion assay in F508del mice – Salivary chloride quantification and its correlation to the human sweat test. Journal of Cystic Fibrosis. 12. S60–S60. 1 indexed citations
8.
9.
Haasbach, Emanuel, Karoline Droebner, Annette B. Vogel, & Oliver Planz. (2011). Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A Viruses In Vitro and In Vivo. Journal of Interferon & Cytokine Research. 31(6). 515–525. 33 indexed citations
10.
Droebner, Karoline, Stephan Pleschka, Stephan Ludwig, & Oliver Planz. (2011). Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Research. 92(2). 195–203. 98 indexed citations
11.
Droebner, Karoline, Stephan Ludwig, Stephan Pleschka, & Oliver Planz. (2011). Antiviral Activity of the MEK-inhibitor U0126 against Pandemic H1N1v and Highly Pathogenic Avian Influenza Virus In Vitro and In Vivo. Antiviral Research. 90(2). A32–A32. 5 indexed citations
12.
13.
Zevgiti, Stella, et al.. (2010). Influenza virus H5N1 hemagglutinin (HA) T‐cell epitope conjugates: design, synthesis and immunogenicity. Journal of Peptide Science. 17(3). 226–232. 2 indexed citations
14.
Vogel, Annette B., Emanuel Haasbach, Sarah J. Reiling, et al.. (2010). Highly Pathogenic Influenza Virus Infection of the Thymus Interferes with T Lymphocyte Development. The Journal of Immunology. 185(8). 4824–4834. 28 indexed citations
15.
Droebner, Karoline, et al.. (2009). Cystus052, a plant extract against seasonal and pandemic influenza virus. Planta Medica. 75(9). 1 indexed citations
16.
Droebner, Karoline, Emanuel Haasbach, Andreas O. Weinzierl, et al.. (2008). Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Vaccine. 26(52). 6965–6974. 27 indexed citations
17.
Droebner, Karoline, et al.. (2008). Early antiviral activity of CYSTUS052 against H5N1 influenza virus is more efficient compared to oseltamivir. Planta Medica. 74(9). 1 indexed citations
18.
Droebner, Karoline, Sarah J. Reiling, & Oliver Planz. (2008). Role of Hypercytokinemia in NF-κB p50-Deficient Mice after H5N1 Influenza A Virus Infection. Journal of Virology. 82(22). 11461–11466. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyan Wu Breakdown of academic impact, for papers by I. Haviv Breakdown of academic impact, for papers by D Pfeil Breakdown of academic impact, for papers by Shyamala Thirunavukkarasu Breakdown of academic impact, for papers by Vera Nief Breakdown of academic impact, for papers by Qingming Dong Breakdown of academic impact, for papers by Weiwen Liang Breakdown of academic impact, for papers by Xiaomei Li Breakdown of academic impact, for papers by Amina Negash Breakdown of academic impact, for papers by Xuelin He
Rankless by CCL
2026